« Mineral Oil Myth | Main | My Body Is My Own Business »
November 26, 2006
Rash And EGFR Inhibitors
If you have cancer and take EGFR in
An acne-like rash or dry skin is a very common side effect of the drugs that target the epidermal growth factor receptor, with approximately 3/4 of patients who receive the EGFR tyrosine kinase inhbitor tarceva/erlotinib experiencing skin toxicity. Similar skin toxicities are also seen, but a bit less commonly, with the very similar drug iressa/gefitinib, and also frequently with erbitux/cetuximab, a monoclonal antibody that is less well studied in lung cancer.
|
Related Products: |
Read more from this blogger: |
Posted on November 26, 2006 01:38 AM by Dry Sk35.
Filed in Skin Care News under dry skin.
Permalink 
| Comments (0)
